Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Pharmacovigilance (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pharmacology, Clinical (MeSH) < Pharmacovigilance (MeSH) < Pharmacy (MeSH)  Facettes :

List of bibliographic references indexed by Pharmacovigilance (MeSH)

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000021 (2021) Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse][Pharmacovigilance update].
000149 (2021) Amir Sarayani [États-Unis] ; Brian Cicali [États-Unis] ; Carl H. Henriksen [États-Unis] ; Joshua D. Brown [États-Unis]Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
000215 (2021) Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
000467 (2021) Elena Beyzarov [États-Unis] ; Yan Chen [États-Unis] ; Rob Julg [États-Unis] ; Karen Naim [États-Unis] ; Jigna Shah [États-Unis] ; William W. Gregory [États-Unis] ; Ayman Ayoub [États-Unis] ; Patrick Caubel [États-Unis]Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
000653 (2021) Adam Goldman [Israël] ; David Bomze [Israël, Suisse] ; Rachel Dankner [Israël] ; Hanoch Hod [Israël] ; Tomer Meirson [Israël] ; Ben Boursi [Israël, États-Unis] ; Elad Maor [Israël]Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
000747 (2021) José Romério Rabelo Melo [Brésil] ; Elisabeth Carmen Duarte [Brésil] ; Marcelo Vogler De Moraes [Brésil] ; Karen Fleck [Brésil] ; Amanda Soares Do Nascimento E. Silva [Brésil] ; Paulo Sérgio Dourado Arrais [Brésil]Adverse drug reactions in patients with COVID-19 in Brazil: analysis of spontaneous notifications of the Brazilian pharmacovigilance system.
000766 (2021) Vakaramoko Diaby [États-Unis] ; Reem D. Almutairi [États-Unis] ; Ziyan Chen [États-Unis] ; Richard K. Moussa ; Abdrahmane Berthe [Canada]A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
000885 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000B46 (2020) Marco Tuccori [Italie] ; Irma Convertino [Italie] ; Sara Ferraro [Italie] ; Emiliano Cappello [Italie] ; Giulia Valdiserra [Italie] ; Daniele Focosi [Italie] ; Corrado Blandizzi [Italie]The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.
000F34 (2020) Kenichiro Sato [Japon] ; Tatsuo Mano [Japon] ; Atsushi Iwata [Japon] ; Tatsushi Toda [Japon]Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
001501 (2020) Peter Yamoah [Ghana, Afrique du Sud] ; Thelma Mpoku Alalbila [Ghana] ; Varsha Bangalee [Afrique du Sud] ; Frasia Oosthuizen [Afrique du Sud]Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion.
001A29 (2020) Jean-Louis Montastruc [France] ; Pierre-Louis Toutain [France, Royaume-Uni]A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Pharmacovigilance (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Pharmacovigilance (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Pharmacovigilance (MeSH)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021